UBS analyst Kevin McVeigh lowered the firm’s price target on ASGN (ASGN) to $47 from $49 and keeps a Sell rating on the shares. The firm remains cautious amid continued core uncertainty, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASGN:
- ASGN’s Mixed Financial Signals and Macroeconomic Challenges Lead to Hold Rating
- ASGN price target lowered to $51 from $56 at Wells Fargo
- ASGN Incorporated Surpasses Revenue Expectations in Q2 2025
- ASGN reports Q2 adjusted EPS $1.17, consensus $1.08
- ASGN sees Q3 adjusted EPS $1.18-$1.26, consensus $1.22